OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)Officer sold ~$2.98M

Joseph Michael Fitzgerald, Officer at Boston Scientific, sold ~$2.98M of Boston Scientific shares.

~$2.98M
Approx. value · 28K sh @ $105.85
178K
Holds after · shares reported
Traded
Sep 2, 2025
Filed
Sep 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  2. Dec 11, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  3. Jun 11, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  4. Jun 26, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  5. Jul 25, 2025InsiderDirector sold ~$424K of BSX shares in the open market
  6. Jul 29, 2025InsiderDirector sold ~$310K of BSX shares in the open market
  7. Jul 31, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  8. Aug 1, 2025Insider · 2 peopleInsiders: 2 sales (~$7.0M)
  9. Aug 4, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  10. Sep 2, 2025 · this disclosureInsiderOfficer sold ~$2.98M of BSX shares in the open market

What came next

  1. Sep 2, 2025InsiderOfficer sold ~$2.29M of BSX shares in the open market
  2. Sep 11, 2025FDARecall: TENACIO Pump without InhibiZone; UPN: 72404420;
  3. Sep 12, 2025FDAFDA device clearance: LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)
  4. Sep 23, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  5. Sep 24, 2025FDAFDA device clearance: LithoVue Elite Single-Use Digital Flexible Ureteroscope - Standard with pressure monitoring (M0067940000); LithoVue Elite Single-Use Digital Flexible Ureterosc…
  6. Sep 26, 2025FDAFDA device clearance: Radial Jaw 4 Pulmonary Biopsy Forceps
  7. Oct 9, 2025FDAFDA device clearance: Orca Air/Water and Suction Valves
  8. Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  9. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
  10. Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
  11. Oct 27, 2025InsiderDirector sold ~$1.01M of BSX shares in the open market
  12. Oct 28, 2025FDAFDA device clearance: TheraSphere 360™ Y-90 Management Platform
  13. Oct 28, 2025InsiderDirector sold ~$297K of BSX shares in the open market
  14. Oct 28, 2025CongressDisclosed partial sale of BSX — reported range $15,001 - $50,000
  15. Oct 30, 2025FDAFDA device clearance: Moses™ 200 D/F/L Laser Fiber (M0068130100); Moses™ 365 D/F/L Laser Fiber (M0068130110); Moses™ 550 D/F/L Laser Fiber (M0068130120)
  16. Oct 30, 2025FDAFDA device clearance: OBSIDIO™ Conformable Embolic (M0013972101010)
  17. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  18. Oct 31, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  19. Nov 3, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
  20. Nov 6, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology

The full history of Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data